Drug Trial Radar · NCT04854707
An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data
Last checked: Nov 19, 2026Latest source record: Oct 22, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
5,484
Actual
Start
Jan 12, 2020
Primary completion
Dec 20, 2020
Study completion Jan 20, 2021
Sponsor
- Lead sponsor
- IVFarma LLCIndustry
- Sponsor type
- Industry
- Collaborators
- Institute for Preventive and Social Medicine
- First posted
- Apr 22, 2021
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- Female only, from 20 years, up to 43 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Aim to investigate the efficacy of follitropin alpha biosimilar therapy (Primapur®) in nonselected real-world population.
Conditions
- Reproductive Issues
- Reproductive Disorder
- Fertility Disorders
- Fertility Issues
- Gynecologic Disease
- IVF
Interventions
Follitropin AlfaDrug
Subcutaneous injection of follitropin alpha biosimilar only, with daily dose 100-300 IU for 10 days, maximum of 15 days, using antagonists of GnRH or agonist of GnRH.
Follicle Stimulating Hormone/Luteinizing HormoneDrug
Subcutaneous injection of follitropin alpha biosimilar, with daily dose 100-300 IU for at least 5 days, than added another gonadotropin for a maximum of 10 days, using antagonists of GnRH or agonist of GnRH.
Follitropin AlfaDrug
Subcutaneous injection of follitropin alpha biosimilar only, with daily dose 100-300 IU for 10 days, maximum of 15 days, using antagonists of GnRH only for suppression.
Follitropin AlfaDrug
Subcutaneous injection of follitropin alpha biosimilar only, with daily dose 100-300 IU for 10 days, maximum of 15 days, using agonists of GnRH only for suppression.
Follicle Stimulating Hormone/Luteinizing HormoneDrug
Overall ovarian stimulation protocols with follitropin alpha biosimilar for at least 5 days+other recombinant and menotropins and short (antagonists of GnRH) or long protocol (agonist of GnRH).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Oocytes RetrievedTime frame: From date of start of ovarian stimulation with follitropin alpha up to 15 days
- Percentage of Participants With Ongoing Clinical Pregnancy Per Embryo TransferTime frame: At least 6 weeks after embryo transfer
Locations
35 sites in 1 country. Site status is shown where the registry gives one.
Center for reproductive medicine, Barnaul
Barnaul, Russia
Center for reproductive medicine, Irkutsk
Irkutsk, Russia
Clinic "Mother and Child" Kazan
Kazan', Russia
Clinic "Mother and Child" Kostroma
Kostroma, Russia
Clinic "Mother and Child" Krasnodar
Krasnodar, Russia
Center for reproductive medicine, Krasnoyarsk
Krasnoyarsk, Russia
AltraVita IVF clinic
Moscow, Russia
Center of Reproductive Medicine and Genetics "Nova Clinic"
Moscow, Russia
Clinic "Mather and Child" Lefortovo
Moscow, Russia
Clinic "Mather and Child" Savelovskaya
Moscow, Russia
Clinic "Mother and Child" Khodynskoe Pole
Moscow, Russia
Clinic "Mother and Child" Kuntsevo
Moscow, Russia
Clinic "Mother and Child" South-West
Moscow, Russia
Clinical Hospital MD GROUP (Perinatal Center on Sevastopolskiy)
Moscow, Russia
Clinical Hospital Lapino
Moscow Oblast, Russia
Clinic "Mother and Child"
Nizhny Novgorod, Russia
Medika-2
Novokuznetsk, Russia
Center for reproductive medicine, Novosibirsk
Novosibirsk, Russia
Clinical Hospital "Avicenna"
Novosibirsk, Russia
Ceter for reproductive medicine, Omsk
Omsk, Russia
Clinic "Mother and Child" Perm
Perm, Russia
Clinic "Mother and Child" Rostov-on-Don
Rostov-on-Don, Russia
Clinic "Mather and Child"
Ryazan, Russia
"Genesis" Reproduction Centre
Saint Petersburg, Russia
Clinic "Mother and Child" Saint-Petersburg
Saint Petersburg, Russia
Clinical Hospital "Mother and Child"
Samara, Russia
Clinic "Mather and Child" Tula
Tula, Russia
Clinical Hospital "Mother and Child"
Tyumen, Russia
Clinical Hospital "Mother and Child"
Ufa, Russia
Clinic "Mother and Child" Vladimir
Vladimir, Russia
Clinic "Mather and Child" Vladivostok
Vladivostok, Russia
Clinic "Mother and Child" Volgograd
Volgograd, Russia
Clinic "Mother and Child" Voronezh
Voronezh, Russia
Clinic "Mother and Child" Yaroslavl
Yaroslavl, Russia
Clinical Institute of Reproductive Medicine
Yekaterinburg, Russia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.